Danielle Daignault

Background

About Danielle Daignault

Dedicated clinical pharmacist with a passion for diabetes health education, medication safety, and patient-centered care. With 20+ years of experience in drug information, patient education, and clinical decision support, I specialize in transforming complex medication information into clear, accessible, and actionable content for both healthcare professionals and patients. As a Clinical Editor at Elsevier, I develop evidence-based medication content for every step of the healthcare workflow, including referential and integrated clinical decision support tools, and patient medication information. I serve as the Diabetes Subject Matter Expert, ensuring the latest research, guidelines, and regulatory updates inform both professional and consumer-facing medical education-helping clinicians and patients make safe, informed decisions about diabetes management. Beyond diabetes education, I have played a critical role in high-impact patient safety initiatives-Apple’s Health App: Co-led the development of consumer-facing medication content for pregnant and breastfeeding patients-Amazon PillPack: provide ongoing clinical decision support for overseeing drug allergy checks to prevent adverse medication reactions. What drives my work is a deep commitment to patient advocacy and health literacy. Medication management requires precise, evidence-based guidance. My role bridges the gap between scientific research and real-world application, ensuring that healthcare information is accurate, accessible, and designed to improve patient outcomes. I am looking to expand my impact in diabetes health education and medication safety, collaborating on initiatives that enhance patient education, optimize clinical workflows, and improve public health outcomes. Open to connecting with health professionals, educators, and organizations focused on diabetes care, patient safety, and healthcare innovation—let’s work together to create smarter, safer, and more effective healthcare solutions.